211 related articles for article (PubMed ID: 31478258)
1. PCAT-1 contributes to cisplatin resistance in gastric cancer through epigenetically silencing PTEN via recruiting EZH2.
Li H; Ma X; Yang D; Suo Z; Dai R; Liu C
J Cell Biochem; 2020 Feb; 121(2):1353-1361. PubMed ID: 31478258
[TBL] [Abstract][Full Text] [Related]
2. HOXD-AS1 confers cisplatin resistance in gastric cancer through epigenetically silencing PDCD4 via recruiting EZH2.
Ye Y; Yang S; Han Y; Sun J; Xv L; Wu L; Ming L
Open Biol; 2019 Sep; 9(9):190068. PubMed ID: 31551012
[TBL] [Abstract][Full Text] [Related]
3. PCAT-1 contributes to cisplatin resistance in gastric cancer through miR-128/ZEB1 axis.
Guo Y; Yue P; Wang Y; Chen G; Li Y
Biomed Pharmacother; 2019 Oct; 118():109255. PubMed ID: 31352238
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of nuclear-enriched abundant transcript 1 confers oxaliplatin resistance to gastric cancer.
Li Y; Peng C; Fang C; Huang K
Cell Biol Int; 2020 Feb; 44(2):446-455. PubMed ID: 31617275
[TBL] [Abstract][Full Text] [Related]
5. siRNA silencing EZH2 reverses cisplatin-resistance of human non-small cell lung and gastric cancer cells.
Zhou W; Wang J; Man WY; Zhang QW; Xu WG
Asian Pac J Cancer Prev; 2015; 16(6):2425-30. PubMed ID: 25824776
[TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA SOX2-OT facilitates laryngeal squamous cell carcinoma development by epigenetically inhibiting PTEN via methyltransferase EZH2.
Tai Y; Ji Y; Liu F; Zang Y; Xu D; Ma S; Qin L; Ma J
IUBMB Life; 2019 Sep; 71(9):1230-1239. PubMed ID: 30811870
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of Long Noncoding RNA HOTAIR and EZH2 Induces Apoptosis and Inhibits Proliferation, Invasion, and Migration of Human Breast Cancer Cells.
Han L; Zhang HC; Li L; Li CX; Di X; Qu X
Cancer Biother Radiopharm; 2018 Aug; 33(6):241-251. PubMed ID: 30048163
[TBL] [Abstract][Full Text] [Related]
8. LncRNA SNHG1 promotes tumor progression and cisplatin resistance through epigenetically silencing miR-381 in breast cancer.
Zhang M; Yang L; Hou L; Tang X
Bioengineered; 2021 Dec; 12(2):9239-9250. PubMed ID: 34806925
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA OIP5-AS1 aggravates cell proliferation, migration in gastric cancer by epigenetically silencing NLRP6 expression via binding EZH2.
Bai Y; Li S
J Cell Biochem; 2020 Jan; 121(1):353-362. PubMed ID: 31219209
[TBL] [Abstract][Full Text] [Related]
10. LncRNA SNHG17 promotes gastric cancer progression by epigenetically silencing of p15 and p57.
Zhang G; Xu Y; Wang S; Gong Z; Zou C; Zhang H; Ma G; Zhang W; Jiang P
J Cell Physiol; 2019 Apr; 234(4):5163-5174. PubMed ID: 30256413
[TBL] [Abstract][Full Text] [Related]
11. LncRNA DANCR promotes migration and invasion through suppression of lncRNA-LET in gastric cancer cells.
Mao Z; Li H; Du B; Cui K; Xing Y; Zhao X; Zai S
Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 28951520
[TBL] [Abstract][Full Text] [Related]
12. The polycomb group protein EZH2 induces epithelial-mesenchymal transition and pluripotent phenotype of gastric cancer cells by binding to PTEN promoter.
Gan L; Xu M; Hua R; Tan C; Zhang J; Gong Y; Wu Z; Weng W; Sheng W; Guo W
J Hematol Oncol; 2018 Jan; 11(1):9. PubMed ID: 29335012
[TBL] [Abstract][Full Text] [Related]
13. HOX transcript antisense intergenic RNA represses E-cadherin expression by binding to EZH2 in gastric cancer.
Chen WM; Chen WD; Jiang XM; Jia XF; Wang HM; Zhang QJ; Shu YQ; Zhao HB
World J Gastroenterol; 2017 Sep; 23(33):6100-6110. PubMed ID: 28970725
[TBL] [Abstract][Full Text] [Related]
14. Exosome-transmitted lncRNA UFC1 promotes non-small-cell lung cancer progression by EZH2-mediated epigenetic silencing of PTEN expression.
Zang X; Gu J; Zhang J; Shi H; Hou S; Xu X; Chen Y; Zhang Y; Mao F; Qian H; Zhu T; Xu W; Zhang X
Cell Death Dis; 2020 Apr; 11(4):215. PubMed ID: 32242003
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA HCP5 contributes to cisplatin resistance in human triple-negative breast cancer via regulation of PTEN expression.
Wu J; Chen H; Ye M; Wang B; Zhang Y; Sheng J; Meng T; Chen H
Biomed Pharmacother; 2019 Jul; 115():108869. PubMed ID: 31028999
[TBL] [Abstract][Full Text] [Related]
16. TUG1 confers Adriamycin resistance in acute myeloid leukemia by epigenetically suppressing miR-34a expression via EZH2.
Li Q; Song W; Wang J
Biomed Pharmacother; 2019 Jan; 109():1793-1801. PubMed ID: 30551433
[TBL] [Abstract][Full Text] [Related]
17. LncRNA PCAT-1 promotes tumour growth and chemoresistance of oesophageal cancer to cisplatin.
Zhen Q; Gao LN; Wang RF; Chu WW; Zhang YX; Zhao XJ; Lv BL; Liu JB
Cell Biochem Funct; 2018 Jan; 36(1):27-33. PubMed ID: 29314203
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA PCAT-1 over-expression promotes proliferation and metastasis in gastric cancer cells through regulating CDKN1A.
Bi M; Yu H; Huang B; Tang C
Gene; 2017 Aug; 626():337-343. PubMed ID: 28571676
[TBL] [Abstract][Full Text] [Related]
19. LINC00511 promotes gastric cancer progression by regulating SOX4 and epigenetically repressing PTEN to activate PI3K/AKT pathway.
Wang Q; Mao X; Luo F; Wang J
J Cell Mol Med; 2021 Oct; 25(19):9112-9127. PubMed ID: 34427967
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA SNHG6 regulates p21 expression via activation of the JNK pathway and regulation of EZH2 in gastric cancer cells.
Li Y; Li D; Zhao M; Huang S; Zhang Q; Lin H; Wang W; Li K; Li Z; Huang W; Che Y; Huang C
Life Sci; 2018 Sep; 208():295-304. PubMed ID: 30031062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
